Samantha L. Shterengarts

Array ( [id] => 14881401 [patent_doc_number] => 10420718 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-24 [patent_title] => Effervescent compositions containing co-crystals of the acid part [patent_app_type] => utility [patent_app_number] => 15/323266 [patent_app_country] => US [patent_app_date] => 2015-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12701 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15323266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11895143 [patent_doc_number] => 09765067 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-19 [patent_title] => 'Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators' [patent_app_type] => utility [patent_app_number] => 15/320813 [patent_app_country] => US [patent_app_date] => 2015-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60241 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15320813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11894055 [patent_doc_number] => 09763975 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2017-09-19 [patent_title] => 'Rheological treatment of brain ischemia by drag reducing polymers' [patent_app_type] => utility [patent_app_number] => 14/789669 [patent_app_country] => US [patent_app_date] => 2015-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 32 [patent_no_of_words] => 6626 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14789669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10489640 [patent_doc_number] => 20150374662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-31 [patent_title] => 'INHIBITORS OF BETA-CATENIN IN TREATMENT OF COLORECTAL CANCER' [patent_app_type] => utility [patent_app_number] => 14/788373 [patent_app_country] => US [patent_app_date] => 2015-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7396 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14788373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10648230 [patent_doc_number] => 09364456 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2016-06-14 [patent_title] => 'Ketone esters for treatment of angelman syndrome' [patent_app_type] => utility [patent_app_number] => 14/755358 [patent_app_country] => US [patent_app_date] => 2015-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 19 [patent_no_of_words] => 6158 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14755358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11864598 [patent_doc_number] => 20170231883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-17 [patent_title] => 'USE OF 4-(3-ETHOXY-4-HYDROXYPHENYL)ALKYLKETONE AS A SKIN-SOOTHING AGENT' [patent_app_type] => utility [patent_app_number] => 15/322535 [patent_app_country] => US [patent_app_date] => 2015-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1941 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15322535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11789502 [patent_doc_number] => 09399039 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2016-07-26 [patent_title] => 'Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use' [patent_app_type] => utility [patent_app_number] => 14/788364 [patent_app_country] => US [patent_app_date] => 2015-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3706 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14788364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10414120 [patent_doc_number] => 20150299130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-22 [patent_title] => 'SELECTIVE HDAC3 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/753913 [patent_app_country] => US [patent_app_date] => 2015-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16464 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14753913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10489688 [patent_doc_number] => 20150374709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-31 [patent_title] => 'TETRA-SUBSTITUTED NDGA DERIVATIVES VIA ETHER BONDS AND CARBAMATE BONDS AND THEIR SYNTHESIS AND PHARMACEUTICAL USE' [patent_app_type] => utility [patent_app_number] => 14/753695 [patent_app_country] => US [patent_app_date] => 2015-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22348 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14753695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11647742 [patent_doc_number] => 20170143642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-25 [patent_title] => 'ACTIVE PHARMACEUTICAL INGREDIENT (API) COMPRISING CANNABINOIDS FOR USE IN THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 15/321766 [patent_app_country] => US [patent_app_date] => 2015-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11189 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15321766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11196798 [patent_doc_number] => 09426992 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2016-08-30 [patent_title] => 'Method for inhibiting conidial germination and mycelial growth of fungi symbiotically associated with bark beetles' [patent_app_type] => utility [patent_app_number] => 14/751617 [patent_app_country] => US [patent_app_date] => 2015-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2656 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14751617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11625798 [patent_doc_number] => 20170135987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-18 [patent_title] => 'THIOUREYLENE LIQUID COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 15/321874 [patent_app_country] => US [patent_app_date] => 2015-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4854 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15321874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11879597 [patent_doc_number] => 09750753 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2017-09-05 [patent_title] => 'Method of treating diseases associated with LRRK2 mutation using hexachlorophene' [patent_app_type] => utility [patent_app_number] => 14/742116 [patent_app_country] => US [patent_app_date] => 2015-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6039 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14742116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14700105 [patent_doc_number] => 10377786 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-13 [patent_title] => Green methods for preparing highly CO2 selective and H2S tolerant metal organic frameworks [patent_app_type] => utility [patent_app_number] => 15/319505 [patent_app_country] => US [patent_app_date] => 2015-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 4523 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15319505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11987720 [patent_doc_number] => 20170291876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-12 [patent_title] => 'ASYMMETRICALLY CATALYZED SYNTHESIS METHOD OF NITROPYRAZOLE AMIDE COMPOUND' [patent_app_type] => utility [patent_app_number] => 15/511243 [patent_app_country] => US [patent_app_date] => 2015-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4044 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15511243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10467045 [patent_doc_number] => 20150352061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-10 [patent_title] => 'METHODS AND COMPOSITIONS FOR INTERFERING WITH EXTRACTION OR CONVERSION OF A DRUG SUSCEPTIBLE TO ABUSE' [patent_app_type] => utility [patent_app_number] => 14/734364 [patent_app_country] => US [patent_app_date] => 2015-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14836 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14734364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11333890 [patent_doc_number] => 09525143 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-20 [patent_title] => 'Triarylamine compound, light-emitting element, light-emitting device, electronic device, and lighting device' [patent_app_type] => utility [patent_app_number] => 14/732097 [patent_app_country] => US [patent_app_date] => 2015-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 39 [patent_no_of_words] => 24024 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14732097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13206979 [patent_doc_number] => 10117840 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-06 [patent_title] => Sulfur(VI) fluoride compounds and methods for the preparation thereof [patent_app_type] => utility [patent_app_number] => 15/316742 [patent_app_country] => US [patent_app_date] => 2015-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 37 [patent_no_of_words] => 43233 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15316742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11714795 [patent_doc_number] => 20170183293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-29 [patent_title] => 'NOVEL EP4 AGONISTS AS THERAPEUTIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 15/316786 [patent_app_country] => US [patent_app_date] => 2015-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19073 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15316786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10459439 [patent_doc_number] => 20150344455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-03 [patent_title] => 'COMPOUNDS, COMPOSITIONS AND METHODS USEFUL FOR CHOLESTEROL MOBILIZATION' [patent_app_type] => utility [patent_app_number] => 14/729908 [patent_app_country] => US [patent_app_date] => 2015-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 63722 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14729908 [rel_patent_id] =>[rel_patent_doc_number] =>)